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Abstract 
Metabolism of drugs in the human body can yield both desirable and undesirable results. 
Some of these side-effects are due to drug-drug interactions, drug-diet interactions, or lack 
of drug specificity. The enzymes that drugs attack are structurally selective and complex; 
therefore, many drugs are very general in structure and could possibly react with a variety 
of enzymes. Indazole has been used as a backbone for several drugs as it has the general 
structure that may react with most P450s. To determine a derivative, or a group of 
derivatives, of indazole that may be reactive only with cytochrome P450 2E1 (CYP2El), 
several indazole derivatives were employed as inhibitors of various P450s in enzyme-
substrate reactions for ICso assays. We hypothesize that the polarity and steric bulk of 
substituents to indazole will control the affinity and selectivity of this class of molecules 
toward P450s, especially CYP2El. We developed ICso assays that indicated the 
efl'ectiveness of the inhibitors in relation to indazole itself. These fmdings will provide 
insight into (1) the effects of substituents to the indazole ring on affinity toward CYP2El, 
and (2) the structural specificity of CYP2E 1. 
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Assessing Specificity oflndazole Derivatives as Inhibitors to CYP2El 
Enzymes and Their Importance within the Body 
Enzymes have been known to exist for over a hundred years. The name itself, 
meaning "in yeast", explajns where they were first discovered. Dr. Benjamin Horowitz 
wrote in 1918 of the recent discoveries made in the area of enzymatic research which 
suggested enzymes to be primarily catalysts produced within and by a cell itself (p. 253). 
The widely known textbook definition of"catalyst" is a substance that increases the rate of 
a reaction but itself remains unaltered. In layman's terms, then, an enzyme is a substance 
produced within a cell to speed up reactions and not be used up or changed in the process. 
It is now known that these enzymes catalyze reactions by lowering the energy required for 
activation of a process. They do this by optimizing either the environment in which the 
reaction takes place or the orientation and/or proximity of reactants. The vitality of these 
enzymes may only be fully understood when one realizes that life is sustained by cellular 
activity. This cellular activity occurs largely due to intracellular chemical reactions 
regulated by catalytic substances such as these enzymes, which can be produced only by 
the cell itself. Therefore, life cannot be sustained without cellular production of enzymes. 
They are present not only within human cells but all living cells. Enzymes were first 
discovered in everyday processes, such as the spoiling of milk, alcoholic fermentation, and 
putrefaction. Various experiments showed that these processes were due not to the living 
cells within the substances but rather due to something within the cells-later found to be 
enzymes. They aid in a vast majority of intracellular reactions, their primary function being 
increasing the rate at which the reactions take place. While Horowitz (1918) acknowledged 
that society had "far from a comprehensive knowledge on the chemical configuration of an 
enzyme", he was on the right path to learning more about these vital cellular components 
(p. 259). 
Cytochrome P450 Enzymes 
Enzymes do not come in one set shape or form. As a whole species, enzymes arc 
not mass-produced by assembly line to be exact copies of one another and serve exactly 
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one function; rather, there are categories of enzymes, designating to each a more specified 
purpose. Within these categories or families, the enzymes may be produced in multitude. 
You may think of the general term "enzyme" as similar to the general term 'jacket". There 
are many different kinds of jackets that have a generally similar function, though they may 
be different colors, sizes, styles, materials, etc. Many of those jackets, with their different 
specifics that make them unique, are mass-produced, though they still differ from another 
mass-produced jacket. Similarly, enzymes serve the same general purpose as described 
earlier, but they also show slight differences that allow them to complete their function in 
different ways. However, these enzymes may also not be so specific that they are ill-
prepared for the unpredictable multitude of compounds and reactions they may encounter. 
As F. P. Guengerich (1993) puts it, "It would be impractical for the body to produce 
elaborate and specific enzymatic machinery to deal with every new molecule that comes 
its way" (p. 440). In terms of fighting off potential toxins, a function largely reliant upon 
enzymes, the body produces multiple generalized lines of defense. The first of these is 
most obviously the immune system. Beyond it, however, stands a class of molecules now 
referred to as the cytochrome P450 (CYP) enzymes. 
The study of such compounds began in late 1950s, when a single enzyme believed 
to be found exclusively in the liver was detected by spectrophotometry at a wavelength of 
450 nanometers (Guengerich, 1993, p. 440). At the time, these compounds were believed 
to function solely in xenobiotic, that is 'foreign chemical compound', metabolism. Since 
then, discoveries in this field have made it clear that there are multiple cytoclU'ome P450 
enzymes with differing functions and cell-type localizations. 
Upon experimental observation of aerobic processes within cells, researchers 
determined that a heme-bearing protein was responsible for the liver-microsomal control 
of oxidation reactions, which led to the aforementioned conclusions. Further 
experimentation revealed that this protein was the component at the end of the electron-
transport chain responsible for catalysis of oxidation, which led to its name, "cytochrome" 
(Guengerich> 1993, p. 442). By definition, as cytochromes, these enzymes are 'iron-
containing proteins that participate in cell respiration as catalysts of oxidation-reduction 
reactions' (Nebert et al. 2013, p. 1). (However, it must be noted that these enzymes are 
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unrelated to the mitochondrial cytocbromes a, b and c. Guengerich (1993) says, 
"Cytochrome P450 enzymes transfer electrons to oxygen, whereas most respiratory 
cytochromes transfer electrons to other proteins" (p. 443).) As experimentation continued, 
the cytochrome P450 enzymes were discovered in eukaryotic mitochondria, requiring iron-
sulfur proteins that were not needed by the liver-microsomal proteins. After findings were 
published by various labs, the existence of multiple types of cytochrome P450 molecules 
was confirmed. lt is now known that these enzymes are found in every type of cell within 
the body, except in red blood cells and skeletal muscle cells, with most of them residing in 
the liver (Guengerich, 1993, p.442). 
The compounds that these enzymes metabolize cannot be categorized solely as 
things we ingest deliberately, although they have proven to be instrwnental in 
understanding the science behind drug metabolism. Many of the xcnobiotics, substances 
foreign to the body, processed by these molecules arc introduced to the body unknowingly 
as environmental pollutants. In addition to metabolizing foreign substances, the 
cytochrome P450 enzymes also play important roles in the metabolism of endogenous 
substances, 'those produced within the body' (Guengerich, 1993, p.440). Since multiple 
types of cytochrome P450 enzymes exist, their function is usually designated exclusively 
either to the processing of foreign chemicals or to the metabolism of endogenous 
substances. 
Relating to the processing of foreign chemicals, more applicably, important 
functions of cytochrome P450 enzymes include drug metabolism and carcinogenic 
response. Drug metabolism, being a large factor in this study, will be discussed in more 
depth later in this paper. Carcinogenic responses activated by the presence of specific 
cytochrome P450 enzymes may be positive or negative, depending upon the enzyme. 
Some P450 enzymes may activate the harmful effects of substances that would otherwise 
be essentially harmless, whereas some other cytochrome P450 enzymes may be responsible 
for the removal of such compounds. This difference in function applies not only to the 
effects of carcinogenic substances but also to the toxic activation of other compounds 
within the body. That is to say that the toxicity of a substance within an individual's 
biological system may be greatly affected by the type and quantity of P450 enzymes 
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present in the system (Guengerich, 1993, p.445). Nelson (2013) says, "Human P450s are 
the basis for sometimes fatal drug interactions and the beneficial conversion of codeine 
into morphine:' (p.4). Therefore, these enzymes may be either beneficial or detrimental in 
mode of action. 
In regard to the modification of endogenous substances, P450 enzymes are crucial 
to the hydroxylation of important molecules within the body. The lack of such 
hydroxylation reactions results in a number of genetic diseases known today, "salt-wasting 
syndrome" for example (Guengerich, 1993, p. 445). Several compounds vital to survival 
are created by reactions directly dependent upon these enzymes. The production of sterols, 
compounds which stabilize the cell membrane structure, depends upon the P450 CYP51. 
Lignin, the molecule responsible for the rigid support in woody plants and the making of 
water conduction vessels within them, is a product of the reactions of CYP73, CYP98 and 
CYP84. Components of pollen are also produced by P450 enzymes, as are the pjgments 
for color in many flowers (Nelson, 2013, p.l-2). They are vital to the synthesis of 
cicosanoids, 20-carbon compounds produced from the modification of arachidonic acid. 
This group of compounds includes vital signaling molecules and molecule transport 
modifiers. Jt has also been shown that these enzymes are involved in the production of 
nitric oxide (NO), a neurotransmitter, blood pressw·e mediator, and natural defender 
against invading pathogens (Guengerich, 1993, p. 446). Nebert, Wikvall> and Miller 
(2013) outline the importance of P450 enzymes in endogenous, or internally originating, 
functions, stating: 
It was proposed that CYP enzymes are important upstream in the synthesis and 
degradation of virtually all non-protein ligands that bind to receptors or activate 
second-messenger pathways regulating growth, differentiation, apoptosis, 
homeostasis and neuroendocrine ftmctions. (p.2) 
Whi le the cytochrome P450 enzymes have been found to exist in every biological kingdom, 
the human genome is of most interest to this study. The P450 enzymes are arranged into 
families and subfamilies, based on percent amino acid sequence identity. Studies have 
found that "the human genome contains 18 CYP families, divided into 41 protein-coding 
subfamilies encoding 57 genes." The CYP2, CYP3, and CYP4 families contain a much 
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larger number of genes than the other families. These three, along with the CYPl family, 
are inducible by a variety of stimuli, whereas the other 14 families function mainly in 
critical life functions, and are thus more likely to be associated with genetic diseases when 
mutated, as mentioned earlier (Nebert et al. 2013, p. 2). The members of these 14 families 
are more unique, having well~defined substrates and functions (Nelson, 2013, p.3). 
Meanwhile, the first 4 families participate primarily in the general metabolism of 
eicosanoids, drugs, and other foreign chemicals. There are now more than 150 known 
eicosanoids, and therefore the enzymes binding them have low specificity. In addition, 
there are a number of sequential redundancies amongst the genes of these P450 families; 
thus, allelic mutations within these enzymes rarely result in serious disease. However, 
single-nucleotide polymorphisms (SNPs) in these genes may result in the inter-individual 
differences aflecting parameters such as drug dosage (Nebert ct al. 2013, p. 5). 
A better understanding of the cytochrome P450 enzymes as a molecular species 
allows us to be able to put this study into full perspective in regard to human biological 
systems and to the world in which we live. 
CYP2El 
The cytochrome P450 enzyme of interest in this study was CYP2E1. It is an 
enzyme that resides in the liver and is involved in its own metabolism and that of several 
other protoxicants, meaning that it regulates the production or degradation of each to 
maintain them in certain amounts. This metabolism is inducible, meaning that the 
production of CYP2E 1 may be affected by the presence or absence of certain stimuli. This 
enzyme is responsible for the activation of many procarcinogens, which is the first step in 
development of "chemically mediated cancers" (Mendoza-Cantu et al. 2006, p.494). 
Growing evidence supports a possible role of CYP2El in gluconeogenesis (Collom et al. 
2007, p.1 ). CYP2E 1 is distinguished from other P450s by its rapid turnover rate, making 
it the most unstable of the liver-microsomal CYPs. Its short half-life leads to quick 
degradation of the enzyme, however its halt:. life is increased when bound by substrates or 
heme-iron ligands, meaning that the binding of this enzyme, and therefore its induction, is 
its primary means of survival (Zhukov et al. 1999, p.453). 
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One of the better-known metabolites of CYP2E1 is ethanol, connecting high 
CYP2E1 expression in the liver to chronic alcohol users. A common result of persistent 
alcohol use is liver toxicity caused by oxidative stress. Oxidative stress is an imbalance 
within a cell in which a reactive oxygen species (ROS), a molecule containing an oxygen 
free radical, pulls electrons from other sources for its own stabiljzation while destabilizing 
the molecules from which it takes the electrons. Alcohol metabolism-mediated liver 
toxicity occurs when such an ROS and the reactive metabolite acetaldehyde cause damage 
within the cell. In occasional drinkers, CYP2E 1 is only mi ldly expressed because the 
metabolism of ethanol in these cases can be handled by alcohol dehydrogenase (ADH). 
ADH is present at very low levels in liver cells. Therefore, as alcohol levels increase, the 
role of CYP2E l is also greater. Its induction by ethanol may occur translationally, post-
translationally, and transcriptionally. CYP2El contributes to the formation of the ROS 
and therefore oxidative stress, which ultimately results in apoptosis (or systematic cell 
death). These processes occur not only in the liver, but also in the brain. CYP2El appears 
to play a dominant role in ethanol-mediated neurodegeneration and neurotoxicity (Jin et al. 
2013, p.l-8). 
CYP2El is also inducible by compounds such as toluene, a systemic toxicant that 
targets primarily the central nervous system and is present in organic solvents to which 
print workers are often exposed (Mendoza-Cantu et al. 2006, p.494). 
Although CYP2El metabolizes many important chemical compounds, which will 
be discussed later, its role in protoxicant and carcinogenic activation suggest the relevance 
of finding better inhibitors for this enzyme. 
Experimental findings suggest the presence of a restrictive active site. This site is 
the oxidizing component of many CYP2El-catalyzed reactions. From previous studies, it 
is known that this oxidation is caused by a heme moiety located at the active site. While 
some active site amino acid residues have been identified, their effect on substrate binding, 
and therefore active site selectivity, remains uncettain. Due to the limited knowledge of 
the CYP2El structure and conformation, and therefore its mechanisms of interaction, most 
stmctural substrate predictions have been made based on a model constructed by 
knowledge of similar CYPs such as CYP2C5. "[This] model predicts CYP2El possesses 
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a hydrophobic channel from the solvent leading to small binding pocket bordered by three 
structural elements" (Collom et al. 2007, p.l, 9-13). (Fig. 1 ). 
Because CYP2El metabolizes such a broad range of compounds, its "metabolic 
processes can involve poorly characterized cooperative interactions" (Hartman et al. 
2013a, p.755). As such, it is difficult to gain much insight into the conformation of the 
enzyme. However, observation of common interactions between CYP2E1 and its 
substrates has allowed for better characterization of conformation. 
Common Substrates and Inhibitors to CYP2El 
Because the structure ofCYP2E1 is highly complex and not yet completely known, 
substrate affinity is difficult to predict and has been partially determined experimentally. 
Through such experimentation it has been found that this enzyme metabolizes a broad 
range of more than 70 chemicals-small, hydrophobic molecules, including monocyclic 
and bicyclic compowtds, such as benzene, acetaminophen, coumarin, caffeine, and 
chorzoxazone, etc. (Collom et al. 2007, p.l) Although many ofthese substrates bind via a 
one-site mechanism, following Michaelis-Menten kinetics, there are several exceptions 
which bind cooperatively at two binding sites (Hartman et al. 2013a, p.756). These insights 
apply to inhibitory binding as well. 
Aromatic and heterocyclic compounds act on CYP2El through uncompetitive and 
mixed inhibition mechanisms, requiring two binding sites-one for the substrate and 
another for the inhibitor (Hartman et al. 20 13h, p.l3). The research of Hartman et al. 
(20 13a) suggested that monocyclic azolcs show two binding events, while bicyclic azoles 
show only one (p.755). The experiments conducted in this study used a compound called 
pyrazole as a standard substrate compared to various derivatives of the compoLmd. 
Pyrazole is a monocyclic compound containing two nitrogen atoms within its ring (Fig. 2). 
Analysis of results showed that the addition of a methyl group to the third or fourth carbons 
on the pyrazolc ring would increase affinity toward CYP2El, however there was no 
increase in affinity when a phenyl group was placed at the third carbon (p.761 ). The 
addition of a second ring showed an even greater increase in affinity for the enzyme and 
inhibitor potency depending on the location of the ring. The aromatization of the second 
ring also causes an increase in affinity and potency (p.762). Steric clashes caused by 
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adding bulky substituents to the rings decreases affinity for CYP2E 1 due to the 
conformation and envirorunent of the binding site. Past docking studies determined that 
the active site heme was located at the end of an access channel that became suddenly 
narrower just past the cooperative site (Levy et al. 2014, p.49-50). (Fig. 1). 
c 
B 
Figure 1 Stylized depiction ofthe CYP2El active site (A), cooperative site (B), and access channel (C). 
The broad group of P450-binding substances, including those we chose as the 
inhibitors of our study, namely the azoles, bind to the enzymes by the formation of an iron-
nitrogen bond. An azole is any five-membered aromatic ring structure containing two 
hetero-atoms, one of which must be a nitrogen atom. The chemically favorable formation 
ofthe iron-nitrogen bond determines the ideal orientation of the compound, which would 
also have some bearing on selectivity of the enzyme (Levy et al. 2014, p.50). Upon forming 
the iron-nitrogen bond, compounds rotate to form more favorable interactions with residues 
along the access channel (Fig. 1) while avoiding steric clashes. For this reason, both 
structure and identity play a vital role in the enzyme active site selectivity and affinity of 
substances for the enzyme. 
As stated earlier, some compounds bind cooperatively to a second site on the 
enzyme, rightly named the "cooperative site" as seen in Fig. 1 (B). Monocyclic azoles fall 
into this category. In the CYP2El enzyme, the cooperative site is located as a platform in 
the channel just above the active site. When a compound binds to the cooperative site, it 
overlaps the compound bound to the active site and a variety of interactions (favorable or 
unfavorable) may occur depending upon the identity and characteristics of each molecule 
and its interactions with the enzyme envirorunent (Levy et al. 2014, p.53). Although 
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previous studies suggested that bicyclic compounds inhibit CYP2El by a single-site 
mechanism, later experimentation found that compounds such as indazole and 
tetrahydroindazole may act cooperatively, indicating greater flexibility ofCYP2El binding 
sites (Hartman et al. 2013a, p.764). 
Larger molecules, such as the bicyclic indazole derivatives used in our 
experimentation, have trouble rotating once reaching the narrowed active site due to their 
steric bulk. Their final orientation may therefore be determined by the interactions that 
occur with residues along the access channel as they travel toward the active site. Factors 
such as these have a great bearing on everyday life. The structme of this enzyme's access 
channel and the residues of which it is composed determine the general rules and 
regulations for any compound seeking to bind to it. This is an example of the selectivity 
of the enzyme. The identity of the compound determines if and how it will be able to enter 
and bind to the enzyme. This is an example of the enzyme's affinity for the compound. 
The interaction of a compound with an enzyme is not quite so simple as the lock and key 
idea so often presented. These interactions, depending upon a variety of factors, may 
produce many different results regarding the compound's effects on the enzyme. This area 
of research is important because it allows one to discover new possibilities for drug 
specificity and to enhance those innovations already discovered. 
Why Indazole? 
Previous experiments revealed the high affinity of CYP2E1 f(>r the fused bicyclic 
compounds indazole (IND) and tetrahydroindazole (THI). (Fig. 2). These compounds 
were found to interact at both the active site and the cooperative site. Experiments showed 
IND and THI to be 200-fold and 1 00-fold more potent than pyrazole, respectively, in 
CYP2El inhibition (Hartman et al. 2013a, p.762-764). 
Because IND is ideal for CYP2El binding, it is rapidly becoming a base unit for 
drug design. However, the molecule occms rarely in nature. It is possible that a more 
potent and natmally occurring derivative could be found. 
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The inhibitory success of IND and THI combined with the previously existing 
information about substituent addition to other compounds for increased affinity brought 
us to the experiment described in this paper. 
Chosen Compounds 
Eight inhibitors were chosen for this study. Indazole (IND) and its derivative 
tetrahydroindazole (THI) were used as references for relative inhibition by other 
compounds. The lack of aromaticity in the second ring of tetrahydroindazole was expected 
to cause a decrease in inhibition. 5-methyl-1H-indazolc and 6-methyl-lH-indazole were 
chosen to compare the effects of having a group on carbon-5 as opposed to carbon-6. 5-
bromo-1 H-indazole was chosen to compare the bromine substituent to the methyl group as 
they arc comparable in size but difl'er significantly in properties. 5-hydroxymcthyl-1 H-
indazole was chosen for its polar hydroxyl group, which was predicted to show low affinity 
toward the hydrophobic binding site of CYP2E 1. 5-phenyl-l H-indazolc was used due to 
Figure 2 
ON N 
H 
Pyrazole 
N~ \N~ 
H 
lndazole 
NO() 
H 
Tetrahydroindazole 
6-methyl~lH-irldazole 5-methyl-lH-Indaz.ole S-brom<r1H-indazole 
N~OH 
'N-v 
H N~ ~N~.JJ N N H 
S~hydroxymethyHH-lndawle S-phenyi-1H·lndazole 3-chloro-1H·pyrazo1o 
(3-4,b]pyridine 
Indazoles used as inhibitors in IC50 assays with CYP2E I. 
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its bulky substituent phenyl ring, which was predicted to be hindered in its inhibition due 
to steric hindrance. Finally, 3-chloro-1H-pyrazolo[3,4-b]pyridine was chosen based on its 
structural similarity to chlorzoxazone (CHZ), a substrate of CYP2El with which reaction 
has been shown to occur at a carbon adjacent to a large chlorine atom. CHZ was first used 
as a well-known skeletal muscle relaxant in drugs such as Paraflex and was known to act 
by binding to CYP2El ("Nurses' Drug Alert," 1986, p.l049-l 050). This final compound 
was expected to cause a significant increase in inhibition, yielding more insight into the 
structure-specificity of CYP2E 1. 
r-------------------------, 
N:>=o 
H 
Ch lorzoxa:tone 
Figure 3 Chlorzoxazone (CHZ), a substrate ofCYP2El known to bind at the carbon adjacent to 
the chlorine atom. 
Goal of the Study 
The goal of this study was to determine the structure-function relationships of 
indazoles as inhibitors for CYP2E1, and perhaps other P450s. The initial step was to 
identify suitable high throughput assay conditions for recombinant P450s, then apply them 
to experimental design and carry out subsequent ICso studies. Knowledge of the inhibition 
of P450s by indazoles will identify how different types of substituents determine affinity 
and selectivity toward each of the enzymes and, in doing so, expand llllderstanding of 
structure-fllllction relationships governing the enzymes' interactions with small molecules. 
Materials 
All chemicals in this study were of at least reagent grade. HPLC-grade acetonitrile 
(CH3CN) and other basic chemicals were purchased from Fisher Scientific. Human 
CYP2El (Supersomes®) were purchased from BD Biosciences (San Jose, CA). Indazole, 
tetrahydroindazole, and components of the NADPH~regenerating system were purchased 
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from Sigma-Aldrich (St. Louis, MO). All remaining inhibitors were purchased from 
Chem-lmpex International (Wood Dale, Illinois). 
Methods 
The steady state kinetics (Km in particular) for the investigated enzymes were 
determined with 7-methoxy-4-trifluoromethyl-coumarin (7-MFC) and 7-ethoxy-4-
trifluoromethyl-coumarin (7-EFC) as substrates, using the fluorescence of their common 
product, 7-hydroxy-trifluoromethylcoumarin. The results were then analyzed using the 
Michaelis-Menten equation to yield a value for the substrate concentration at which the 
enzyme works most efficiently. The Km value was then used to set the substrate 
concentration for ICso experiments with indazole derivatives. Finally, ICso values could 
then be used to estimate K i values, inhibitor concentration of greatest efficiency, using the 
Chcng-Prusoff equation. 
Km assays 
For this experiment, substrates of varying concentrations in methanol were diluted 
to 4% methanol in 50 mM potassium phosphate pH 7.4 (KPi 7.4). The wells were prepared 
with 17 JJ.L of deionized water, 2 f.!L of 50 mM KPi 7 .4, 1 J.!L of enzyme, and 10 f.!L of 
diluted substrate (7MFC). NADPH solution at a concentration of 4 mM was prepared and 
incubated along with the well plate in a shaking incubator for 5 min at 3 7°C with shaking 
at 350 rotations per minute. Of the incubated NADPH, 10 J.lL was added to each of the 
wells. The reaction plate was incubated for 30 min at 37°C at 350 rotations per minute. 
Reactions were quco.ched by adding 30 f.!L of reaction mixture to 30 J.!L acetonitrile that 
had been chilled on ice for 10 min in a black well plate. Fluorescence of the product 
solutions was measured on a plate reader. Fluorescence values were then analyzed using 
Excel-values were blank adjusted, and product concentrations were calculated based on 
the standard curve. Rates of reaction were then calculated by taking the time of reaction 
(30 min) into account. All data was then analyzed in GraphPad Prism 5 (Fig. 3), to give a 
Km value. 
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Figure 3 Michaelis-Menten curve or reaction of7-MFC and CYP2EI expressed as a function of7-
MFC concentration. 
/Cso assays 
For this experiment, inhibitors of varying concentrations in methanol were diluted 
to 2% methanol in 50 mM KPi 7.4. Substrate at a concentration of 50 mM was diluted 10-
fold in 50 mM K.Pi 7.4. The wells were prepared with 1 IlL of enzyme, 0.4 '-"L of diluted 
substrate, 10 ML of diluted inhibitor, and 18.6 '-"L of 50 mM KPi 7.4. NADPH solution at 
a concentration of 4 mM was prepared and incubated along with the well plate in a shaking 
incubator for 5 min at 37°C at 350 rotations per minute. Of the incubated NADPH, 10 ML 
was added to the wells. The reaction plate was incubated for 60 min at 37°C with shaking 
at 350 rotations per minute. Reactions were quenched by adding 30 IlL of reaction mixture 
to 30 ML acetonitrile that had been chilled on ice for 10 min in a black well p)ate. 
Fluorescence ofthc product solutions was measured on a plate reader. Fluorescence values 
were then analyzed using Excel-the values were blank adjusted, then percent relative 
activity was calcu)ated asswning 100% at OMM inhibitor. All data was then analyzed in 
GraphPad Prism 5 (Fig. 4), to give an ICso value. 
Results and Discussion 
We investigated the structure-function relationships for a number of indazoles to 
assess the impact of substhuents on affinity for and inhibition of CYP2E 1 as a foundation 
for their potential to be high-affinity and selective inhibitors of P450s. We were only able 
to explore reactions of the inhibitors with one P450, CYP2E 1. The results of this study 
were able to give significant insight into the structural preferences of CYP2El. We were 
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able to determine affinity effects of the given substituents; however selectivity information 
was not established. 
The Km o.f7-MFC with CYP2E 1 was foW1d to be approximately 33 ~J..M. This value 
and the concentration of substrate being held constant in all experimental runs allows us to 
directly compare ICso values, as seen in Figure 4. 
Loss of aromaticity with THI led to a slight decrease in affinity, as expected, 
although significantly less than reported previously with more in-depth spectral binding 
and inhibition kinetic studies (Collom et al. 2007, p.9). The current observation may reflect 
differences in experimental design, but would require further study for verification. 
Substituent addition at position 5 altered binding to CYP2El. A methyl group 
slightly increased affinity, whereas the presence of a phenyl group had a more pronounced 
effect indicating that bulkier, hydrophobic groups improve affinity at position 5. A 
bromine at position 5 had a similar effect as a methyl group. Not surprisingly, the presence 
of a polaT hydroxyl group on the 5-hydroxymethyl group led to a three-fold decrease in 
binding. 
By contrast, the addition of a methyl group at position 6 had an effect on affinity 
quantifiably simi tar to that of indazole, suggesting a lack of significant interaction of the 
methyl group with the enzyme. 
In the case ofthe 3-chloro derivative, the large halide close to the site binding with 
the heme led to a significant six-fold increase in affinity. The increase in affinity may 
improve selectivity for CYP2El given a similar effect for chlorzoxaz.onc even though the 
drug binds relatively poorly to the enzyme. As seen in Fig. 4, the maximum inhibition 
caused by this compoW1d is only 50%, while the others reach approximately 80-90% 
inhibition. Further study would be required to determine possible reasons that the 
compound binds tightly to the enzyme but does not cause a great decrease in enzyme 
activity. These results could reflect a conformational change of the binding site because 
of the inhibitor, which could still allow some enzyme-substrate interaction despite the 
inhibitor being bow1d to the enzyme. These possibilities should be further studied as they 
could also lead to new insights on enzyme function within the body. 
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This study established, as expected, that affinity ofindazole for CYP2El is greater 
than that of tetrahydroindazole, due to the aromaticity of the indazole rings. It was 
detennined that placing a hydrophobic group on the 5th carbon significantly improves 
affinity, while a polar group at this position decreases affinity and the presence of smaller 
non-polar groups at this position show slight improvement. Addition to the sixth carbon 
showed little interaction and change in activity from the standard indazole. Finally, the 
presence of a large halide close to the binding site showed significant improvement in 
affinity. Overall, these trends provide important insights on CYP2El binding ofindazole 
and will be bolstered by in-depth kinetic inhibition studies to confirm these trends and 
provide mechanisms of inhibition. With these interactions in mind, further discoveries 
may be made as to the possible structural changes and the binding characteristics of the 
enzyme that were previously unknown. 
Future Studies 
Because experimental replicates are needed to decrease noise in the data and more 
clearly define trends, more assays should be run under the same conditions using different 
inhihitor concentrations. More steric groups may further enhance binding. A study of the 
3-chloro derivative may provide insights on possible partial binding of the enzyme. Lastly, 
indazoles will be used as inhibitors against other P450s to assess affinity and selectivity 
among them. It is hoped that the results of more studies will help to identify the structure-
specificity relationship of CYP2El and provide more insight into the structure effects on 
the selectivity of indazoles toward P450s. 
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Figure 4 inhibition of CYP2El activity expressed as % relative activity as a function of inhibitor 
concentration. Experiments were performed three times with technical duplicates of each inhibitor 
concentration in each of the experimental replicates (n=6). ICso values and the corresponding 95% 
confidence intervals. 
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